• Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going

    9 days ago - By Fierce Biotech

    Clover raises $230M as COVID-19 vaccine nears phase 3, multivariant prospect gets going ntaylor
    Tue, 02/23/2021 - 08:13
    Read more ...